NEW YORK, March 28, 2022 /PRNewswire/ — The “Cellular Health Screening Market by Geography (North America, Europe, APAC, and Rest of World (ROW)) – Forecast and Analysis 2022-2026″ report has been added to Technavio’s offering. With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies for over 16 years.
The potential growth difference for the cellular health screening market from 2021 and 2026 is USD 1.92 billion. To get the exact yearly growth variance and the Y-O-Y growth rate, Download Free Sample Report.
Key Market Dynamics:
- Market Driver
- The expanding applications of cellular health screening in personalized medicine are one of the primary factors driving the worldwide industrial market expansion. Medical misdiagnosis affects a large number of people in the United States, and the elements that cause it can be delayed, leading to the wrong diagnosis.
- Misdiagnosis has been shown to cause actual injury to patients, resulting in lasting impairment or death. In the United States, it is estimated that unneeded or inaccurate diagnoses account for 30-32% of annual healthcare spending. As a result of its tailored treatment pathways, personalized medicine improves clinical practice quality while lowering total healthcare costs in this scenario.
- Market Challenges
- One of the major impediments to the global industrial market’s expansion is a scarcity of qualified laboratory specialists. The majority of medical personnel are unaware of the technology, its advantages, and how to handle patients during point-of-care (POC) testing. Routine laboratory processes, such as adequate patient preparation, sample collection, calibration, instrument maintenance, and quality control, are foreign to many medical workers.
To learn about additional key drivers, trends, and challenges available with Technavio. Read our FREE Sample Report right now!
The expanding applications of cellular health screening in personalized medicine are one of the primary factors driving the worldwide industrial market expansion. Medical misdiagnosis affects a large number of people in the United States, and the elements that cause it can be delayed, leading to the wrong diagnosis.
Misdiagnosis has been shown to cause actual injury to patients, resulting in lasting impairment or death. In the United States, it is estimated that unneeded or inaccurate diagnoses account for 30-32% of annual healthcare spending. As a result of its tailored treatment pathways, personalized medicine improves clinical practice quality while lowering total healthcare costs in this scenario.
One of the major impediments to the global industrial market’s expansion is a scarcity of qualified laboratory specialists. The majority of medical personnel are unaware of the technology, its advantages, and how to handle patients during point-of-care (POC) testing. Routine laboratory processes, such as adequate patient preparation, sample collection, calibration, instrument maintenance, and quality control, are foreign to many medical workers.
The cellular health screening market report is segmented by Geography (North America, Europe, APAC, and the Rest of the World (ROW)). North America will be the leading region with 40% of the market’s growth during the forecast period. The US, China, India, Germany, and the UK are the key market for cellular health screening in North America.
Over the forecast period, increased insurance coverage, increased R&D expenditure, an increase in the geriatric population with chronic diseases, high healthcare spending, and increased promotions about the use of point-of-care (POC) tests for early disease detection will aid the cellular health screening market growth in North America.
View our sample report for additional insights into the contribution of all the segments, and regional opportunities in the report.
Key Segment Analysis
During the projected period, the office segment’s cellular health screening market share will expand significantly. Although many cellular health screening tests are available directly to patients, several companies prefer to have their services delivered by a physician to assure patient safety and sample collection accuracy. In the next years, such factors will propel the worldwide cellular health screening market through the office segment.
Read Free Sample Report: to know additional highlights and key points on various market segments and their impact in coming years.
Vendor Insights
Cellular Health Screening Market is fragmented, and the vendors are deploying various organic and inorganic growth strategies to compete in the market.
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market.
Some Companies Mentioned with their Offerings·
- Bondi Health & Wellness
- Cell Science Systems Ltd. Corp.
- Genova Diagnostics Inc.
- Immundiagnostik AG
- Laboratory Corp. of America Holdings
- Life Length SL
- OPKO Health Inc.
- Quest Diagnostics Inc.
- Repeat Diagnostics Inc.
- SpectraCell Laboratories Inc.
- Telomere Diagnostics Inc.
To gain access to more vendor profiles with their key offerings available with Technavio, Click Here
Customize Your Report
Don’t miss out on the opportunity to speak to our analyst and know more insights about this market report. Our analysts can also help you customize this report according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
We offer USD 1,000 worth of FREE customization at the time of purchase. Speak to our Analyst now!
Related Reports:
Glycobiology Market by Application and Geography – Forecast and Analysis 2022-2026
Medical Tapes and Bandages Market by End-user and Geography – Forecast and Analysis 2022-2026
Table of Contents
Cellular Health Screening Market Scope
Report Coverage
Details
Page number
120
Base year
2021
Forecast period
2022-2026
Growth momentum & CAGR
Decelerate at a CAGR of 11.24%
Market growth 2022-2026
$ 1.92 billion
Market structure
Fragmented
YoY growth (%)
14.89
Regional analysis
North America, Europe, APAC, and Rest of World (ROW)
Performing market contribution
North America at 40%
Key consumer countries
US, China, India, Germany, and UK
Competitive landscape
Leading companies, competitive strategies, consumer engagement scope
Companies profiled
Bondi Health & Wellness, Cell Science Systems Ltd. Corp., Genova Diagnostics Inc., Immundiagnostik AG, Laboratory Corp. of America Holdings, Life Length SL, OPKO Health Inc., Quest Diagnostics Inc., Repeat Diagnostics Inc., SpectraCell Laboratories Inc., and Telomere Diagnostics Inc.
Market Dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Channel
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
Exhibit 01: Executive Summary – Chart on Market Overview
Exhibit 02: Executive Summary – Data Table on Market Overview
Exhibit 03: Executive Summary – Chart on Global Market Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by Channel
Exhibit 06: Executive Summary – Chart on Incremental Growth
Exhibit 07: Executive Summary – Data Table on Incremental Growth
Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
Exhibit 11: Offerings of vendors included in the market definition
Exhibit 12: Market segments
Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4.1 Five forces summary
Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
5 Market Segmentation by Channel
Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
5.1 Market segments
Exhibit 24: Chart on Channel – Market share 2021-2026 (%)
Exhibit 25: Data Table on Channel – Market share 2021-2026 (%)
5.2 Comparison by Channel
Exhibit 26: Chart on Comparison by Channel
Exhibit 27: Data Table on Comparison by Channel
5.3 Office – Market size and forecast 2021-2026
Exhibit 28: Chart on Office – Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Office – Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Office – Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Office – Year-over-year growth 2021-2026 (%)
5.4 Hospital – Market size and forecast 2021-2026
Exhibit 32: Chart on Hospital – Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Hospital – Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Hospital – Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Hospital – Year-over-year growth 2021-2026 (%)
5.5 Diagnostic labs – Market size and forecast 2021-2026
Exhibit 36: Chart on Diagnostic labs – Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Diagnostic labs – Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Diagnostic labs – Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Diagnostic labs – Year-over-year growth 2021-2026 (%)
5.6 Home – Market size and forecast 2021-2026
Exhibit 40: Chart on Home – Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Home – Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Home – Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Home – Year-over-year growth 2021-2026 (%)
5.7 Others – Market size and forecast 2021-2026
Exhibit 44: Chart on Others – Market size and forecast 2021-2026 ($ million)
Exhibit 45: Data Table on Others – Market size and forecast 2021-2026 ($ million)
Exhibit 46: Chart on Others – Year-over-year growth 2021-2026 (%)
Exhibit 47: Data Table on Others – Year-over-year growth 2021-2026 (%)
5.8 Market opportunity by Channel
Exhibit 48: Market opportunity by Channel ($ million)
6 Customer Landscape
Exhibit 24: Chart on Channel – Market share 2021-2026 (%)
Exhibit 25: Data Table on Channel – Market share 2021-2026 (%)
Exhibit 26: Chart on Comparison by Channel
Exhibit 27: Data Table on Comparison by Channel
Exhibit 28: Chart on Office – Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Office – Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Office – Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Office – Year-over-year growth 2021-2026 (%)
Exhibit 32: Chart on Hospital – Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Hospital – Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Hospital – Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Hospital – Year-over-year growth 2021-2026 (%)
Exhibit 36: Chart on Diagnostic labs – Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Diagnostic labs – Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Diagnostic labs – Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Diagnostic labs – Year-over-year growth 2021-2026 (%)
Exhibit 40: Chart on Home – Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Home – Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Home – Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Home – Year-over-year growth 2021-2026 (%)
Exhibit 44: Chart on Others – Market size and forecast 2021-2026 ($ million)
Exhibit 45: Data Table on Others – Market size and forecast 2021-2026 ($ million)
Exhibit 46: Chart on Others – Year-over-year growth 2021-2026 (%)
Exhibit 47: Data Table on Others – Year-over-year growth 2021-2026 (%)
Exhibit 48: Market opportunity by Channel ($ million)
6.1 Customer landscape overview
Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7.1 Geographic segmentation
Exhibit 50: Chart on Market share by geography 2021-2026 (%)
Exhibit 51: Data Table on Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 52: Chart on Geographic comparison
Exhibit 53: Data Table on Geographic comparison
7.3 North America – Market size and forecast 2021-2026
Exhibit 54: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on North America – Year-over-year growth 2021-2026 (%)
7.4 Europe – Market size and forecast 2021-2026
Exhibit 58: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Europe – Year-over-year growth 2021-2026 (%)
7.5 APAC – Market size and forecast 2021-2026
Exhibit 62: Chart on APAC – Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on APAC – Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on APAC – Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on APAC – Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) – Market size and forecast 2021-2026
Exhibit 66: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
7.7 US – Market size and forecast 2021-2026
Exhibit 70: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on US – Year-over-year growth 2021-2026 (%)
7.8 Germany – Market size and forecast 2021-2026
Exhibit 74: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
7.9 UK – Market size and forecast 2021-2026
Exhibit 78: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK – Year-over-year growth 2021-2026 (%)
7.10 China – Market size and forecast 2021-2026
Exhibit 82: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on China – Year-over-year growth 2021-2026 (%)
7.11 India – Market size and forecast 2021-2026
Exhibit 86: Chart on India – Market size and forecast 2021-2026 ($ million)
Exhibit 87: Data Table on India – Market size and forecast 2021-2026 ($ million)
Exhibit 88: Chart on India – Year-over-year growth 2021-2026 (%)
Exhibit 89: Data Table on India – Year-over-year growth 2021-2026 (%)
7.12 Market opportunity by geography
Exhibit 90: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
Exhibit 50: Chart on Market share by geography 2021-2026 (%)
Exhibit 51: Data Table on Market share by geography 2021-2026 (%)
Exhibit 52: Chart on Geographic comparison
Exhibit 53: Data Table on Geographic comparison
Exhibit 54: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibit 58: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibit 62: Chart on APAC – Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on APAC – Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on APAC – Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on APAC – Year-over-year growth 2021-2026 (%)
Exhibit 66: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibit 70: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibit 74: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibit 78: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibit 82: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibit 86: Chart on India – Market size and forecast 2021-2026 ($ million)
Exhibit 87: Data Table on India – Market size and forecast 2021-2026 ($ million)
Exhibit 88: Chart on India – Year-over-year growth 2021-2026 (%)
Exhibit 89: Data Table on India – Year-over-year growth 2021-2026 (%)
Exhibit 90: Market opportunity by geography ($ million)
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 91: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
Exhibit 91: Impact of drivers and challenges in 2021 and 2026
9.1 Overview
9.2 Vendor landscape
Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 93: Overview on factors of disruption
9.4 Industry risks
Exhibit 94: Impact of key risks on business
10 Vendor Analysis
Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
Exhibit 93: Overview on factors of disruption
Exhibit 94: Impact of key risks on business
10.1 Vendors covered
Exhibit 95: Vendors covered
10.2 Market positioning of vendors
Exhibit 96: Matrix on vendor position and classification
10.3 Bondi Health Wellness
Exhibit 97: Bondi Health Wellness – Overview
Exhibit 98: Bondi Health Wellness – Product / Service
Exhibit 99: Bondi Health Wellness – Key offerings
10.4 Cell Science Systems Ltd. Corp.
Exhibit 100: Cell Science Systems Ltd. Corp. – Overview
Exhibit 101: Cell Science Systems Ltd. Corp. – Product / Service
Exhibit 102: Cell Science Systems Ltd. Corp. – Key offerings
10.5 Immundiagnostik AG
Exhibit 103: Immundiagnostik AG – Overview
Exhibit 104: Immundiagnostik AG – Product / Service
Exhibit 105: Immundiagnostik AG – Key news
Exhibit 106: Immundiagnostik AG – Key offerings
10.6 Laboratory Corp. of America Holdings
Exhibit 107: Laboratory Corp. of America Holdings – Overview
Exhibit 108: Laboratory Corp. of America Holdings – Business segments
Exhibit 109: Laboratory Corp. of America Holdings – Key offerings
Exhibit 110: Laboratory Corp. of America Holdings – Segment focus
10.7 Life Length SL
Exhibit 111: Life Length SL – Overview
Exhibit 112: Life Length SL – Product / Service
Exhibit 113: Life Length SL – Key offerings
10.8 OPKO Health Inc.
Exhibit 114: OPKO Health Inc. – Overview
Exhibit 115: OPKO Health Inc. – Business segments
Exhibit 116: OPKO Health Inc. – Key news
Exhibit 117: OPKO Health Inc. – Key offerings
Exhibit 118: OPKO Health Inc. – Segment focus
10.9 Quest Diagnostics Inc.
Exhibit 119: Quest Diagnostics Inc. – Overview
Exhibit 120: Quest Diagnostics Inc. – Business segments
Exhibit 121: Quest Diagnostics Inc. – Key offerings
Exhibit 122: Quest Diagnostics Inc. – Segment focus
10.10 Repeat Diagnostics Inc.
Exhibit 123: Repeat Diagnostics Inc. – Overview
Exhibit 124: Repeat Diagnostics Inc. – Product / Service
Exhibit 125: Repeat Diagnostics Inc. – Key offerings
10.11 SpectraCell Laboratories Inc.
Exhibit 126: SpectraCell Laboratories Inc. – Overview
Exhibit 127: SpectraCell Laboratories Inc. – Product / Service
Exhibit 128: SpectraCell Laboratories Inc. – Key offerings
10.12 Telomere Diagnostics Inc.
Exhibit 129: Telomere Diagnostics Inc. – Overview
Exhibit 130: Telomere Diagnostics Inc. – Product / Service
Exhibit 131: Telomere Diagnostics Inc. – Key offerings
11 Appendix
Exhibit 95: Vendors covered
Exhibit 96: Matrix on vendor position and classification
Exhibit 97: Bondi Health Wellness – Overview
Exhibit 98: Bondi Health Wellness – Product / Service
Exhibit 99: Bondi Health Wellness – Key offerings
Exhibit 100: Cell Science Systems Ltd. Corp. – Overview
Exhibit 101: Cell Science Systems Ltd. Corp. – Product / Service
Exhibit 102: Cell Science Systems Ltd. Corp. – Key offerings
Exhibit 103: Immundiagnostik AG – Overview
Exhibit 104: Immundiagnostik AG – Product / Service
Exhibit 105: Immundiagnostik AG – Key news
Exhibit 106: Immundiagnostik AG – Key offerings
Exhibit 107: Laboratory Corp. of America Holdings – Overview
Exhibit 108: Laboratory Corp. of America Holdings – Business segments
Exhibit 109: Laboratory Corp. of America Holdings – Key offerings
Exhibit 110: Laboratory Corp. of America Holdings – Segment focus
Exhibit 111: Life Length SL – Overview
Exhibit 112: Life Length SL – Product / Service
Exhibit 113: Life Length SL – Key offerings
Exhibit 114: OPKO Health Inc. – Overview
Exhibit 115: OPKO Health Inc. – Business segments
Exhibit 116: OPKO Health Inc. – Key news
Exhibit 117: OPKO Health Inc. – Key offerings
Exhibit 118: OPKO Health Inc. – Segment focus
Exhibit 119: Quest Diagnostics Inc. – Overview
Exhibit 120: Quest Diagnostics Inc. – Business segments
Exhibit 121: Quest Diagnostics Inc. – Key offerings
Exhibit 122: Quest Diagnostics Inc. – Segment focus
Exhibit 123: Repeat Diagnostics Inc. – Overview
Exhibit 124: Repeat Diagnostics Inc. – Product / Service
Exhibit 125: Repeat Diagnostics Inc. – Key offerings
Exhibit 126: SpectraCell Laboratories Inc. – Overview
Exhibit 127: SpectraCell Laboratories Inc. – Product / Service
Exhibit 128: SpectraCell Laboratories Inc. – Key offerings
Exhibit 129: Telomere Diagnostics Inc. – Overview
Exhibit 130: Telomere Diagnostics Inc. – Product / Service
Exhibit 131: Telomere Diagnostics Inc. – Key offerings
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 132: Inclusions checklist
Exhibit 133: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 134: Currency conversion rates for US$
11.4 Research methodology
Exhibit 135: Research methodology
Exhibit 136: Validation techniques employed for market sizing
Exhibit 137: Information sources
11.5 List of abbreviations
Exhibit 138: List of abbreviations
About UsTechnavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Exhibit 132: Inclusions checklist
Exhibit 133: Exclusions checklist
Exhibit 134: Currency conversion rates for US$
Exhibit 135: Research methodology
Exhibit 136: Validation techniques employed for market sizing
Exhibit 137: Information sources
Exhibit 138: List of abbreviations
ContactTechnavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email:[email protected]Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/cellular-health-screening-market-size-to-grow-by-usd-1-92-bn-40-of-the-growth-to-originate-from-north-america-technavio-301510933.html
SOURCE Technavio
Disclaimer: The above press release comes to you under an arrangement with PR Newswire. TheTechOutlook.com takes no editorial responsibility for the same.
